MIGUEL ÁNGEL GALLO MEZO-rekin lankidetzan egindako argitalpenak (3)

2000

  1. Modulation of myogenic differentiation in a human rhabdomyosarcoma cell line by a new derivative of 5-fluorouracil (QF-3602)

    Japanese Journal of Cancer Research, Vol. 91, Núm. 9, pp. 934-940

1999

  1. GR-891: A novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells

    British Journal of Cancer, Vol. 79, Núm. 5-6, pp. 807-813

1997

  1. Chemical modifications on the acyclic moiety of 3-(2-hydroxyethoxy)-1-alkoxypropyl nucleobases. 2. Differentiation and growth inhibition in rhabdorayosarcoma cells after exposure to a novel 5-fluorouracil acyclonucleoside

    Tetrahedron, Vol. 53, Núm. 21, pp. 7319-7334